The Cost-Effectiveness of Losartan in Type 2 Diabetics With Nephropathy in Switzerland - an Analysis of the RENAAL Study. Swiss Med Wkly 2004, 134 (3132), 440-447. https://doi.org/10.4414/smw.2004.10492.